Acute Crit Care.  2020 Nov;35(4):307-308. 10.4266/acc.2020.00416.

Role of vitamin C in critically ill patients with COVID-19: is it effective?

• Chaudhary SMD
• Wright RM
• Patarroyo-Aponte G

• KMID: 2510552
• DOI: http://doi.org/10.4266/acc.2020.00416

Reference

1. Hwang SY, Park JE, Jo IJ, Kim S, Chung SP, Kong T, et al. Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial. Trials. 2019; 20:420.

2. Hager DN, Hooper MH, Bernard GR, Busse LW, Ely EW, Fowler AA, et al. The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial. Trials. 2019; 20:197.

3. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004; 140:533–7.

4. Zabet MH, Mohammadi M, Ramezani M, Khalili H. Effect of high-dose Ascorbic acid on vasopressor’s requirement in septic shock. J Res Pharm Pract. 2016; 5:94–100.

5. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002; 236:814–22.

6. Hemilä H, Chalker E. Vitamin C can shorten the length of stay in the ICU: a meta-analysis. Nutrients. 2019; 11:708.

7. Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020; 92:2283–5.

8. Peng Z. Vitamin C infusion for the treatment of severe 2019-nCoV infected pneumonia: NCT04264533. Bethesda: ClinicalTrials.gov;2020.

9. Lamontagne F. Lessening Organ Dysfunction With VITamin C - COVID-19 (LOVIT-COVID): NCT04401150. Bethesda: ClinicalTrials.gov;2020.

10. Davis BC. Administration of intravenous vitamin C in novel coronavirus infection (COVID-19) and decreased oxygenation (AVoCaDO): NCT04401150. Bethesda: ClinicalTrials.gov;2020.